<code id='23127C1A3A'></code><style id='23127C1A3A'></style>
    • <acronym id='23127C1A3A'></acronym>
      <center id='23127C1A3A'><center id='23127C1A3A'><tfoot id='23127C1A3A'></tfoot></center><abbr id='23127C1A3A'><dir id='23127C1A3A'><tfoot id='23127C1A3A'></tfoot><noframes id='23127C1A3A'>

    • <optgroup id='23127C1A3A'><strike id='23127C1A3A'><sup id='23127C1A3A'></sup></strike><code id='23127C1A3A'></code></optgroup>
        1. <b id='23127C1A3A'><label id='23127C1A3A'><select id='23127C1A3A'><dt id='23127C1A3A'><span id='23127C1A3A'></span></dt></select></label></b><u id='23127C1A3A'></u>
          <i id='23127C1A3A'><strike id='23127C1A3A'><tt id='23127C1A3A'><pre id='23127C1A3A'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:41447
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

          MollyFerguson/STATThisweek,apreviewoftheTUDCAstudyinALSandthoughtsonhowitmightimpactAmylyxPharmaceut

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Abridge raises $150m as clinical notes automation market heats up

          AdobeAPittsburghartificialintelligencestartupemergingasachallengertoMicrosoft’sclinicalnotetakingbus